BAX's second-quarter results may reflect pressured earnings and sales as manufacturing inefficiencies, inflation, and product ...

Baxter International has rebounded 21% YTD, outperforming after a prolonged decline, but I maintain a hold rating. BAX’s Q1 ...

Baxter International Inc. (BAX), headquartered in Deerfield, Illinois, develops and provides a portfolio of healthcare products. With a market cap of $11.7 billion, the company develops, manufactures, ...

Baxter trades at $22.13 and has moved in lockstep with the market. Its shares have returned 10% over the last six months ...

Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...

Baxter stock (NYSE: BAX), a healthcare company, currently trades at $38 per share, more than 50% lower than the level seen in February 2022. BAX stock has fared worse than its peer – Becton, Dickinson ...

Baxter stock (NYSE: BAX), a healthcare company, has seen its stock decline by 14% over the past month. This drop followed a disappointing earnings report where the company also reduced its full-year ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.